Distinct epitopes for anti-glomerular basement membrane Alport alloantibodies and Goodpasture autoantibodies within the noncollagenous domain of α3(IV) collagen: A janus-faced antigen

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3563-3571

  Wang, Xu Ping ^a   Fogo, Agnes B ^a   Colon, Selene ^a   Giannico, Giovanna ^a   Abul Ezz, Sameh R ^b   Miner, Jeffrey H ^c   Borza, Dorin Bogdan ^a,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; COLLAGEN TYPE 4; CYCLOPHOSPHAMIDE; EPITOPE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; JANUS KINASE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN SUBUNIT; TACROLIMUS; ANTIBODY; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY; COLLAGEN;

ADULT; ALPORT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GOODPASTURE SYNDROME; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; KIDNEY BIOPSY; MOUSE; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; CASE REPORT; CHRONIC KIDNEY FAILURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; HISTOCOMPATIBILITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; NEEDLE BIOPSY; NEPHRITIS; PATHOLOGY; PHYSIOLOGY; RISK ASSESSMENT;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES; BIOPSY, NEEDLE; COLLAGEN; COLLAGEN TYPE IV; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FATAL OUTCOME; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEPHRITIS, HEREDITARY; RISK ASSESSMENT; TRANSPLANTATION IMMUNOLOGY;

EID: 33645914468     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005060670     Document Type: Article

References (40)

1. Miner JH, Sanes JR: Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and developmental switches. J Cell Biol 127: 879-891, 1994
2. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99: 2470-2478, 1997
3. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248: 1224-1227, 1990
4. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, Reeders ST: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77-81, 1994
5. Lemmink HH, Mochizuki T, van den Heuvel LP, Schroder CH, Barrientos A, Monnens LA, van Oost BA, Brunner HG, Reeders ST, Smeets HJ: Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3: 1269-1273, 1994
6. Kashtan CE, Michael AF: Alport syndrome. Kidney Int 50: 1445-1463, 1996
7. McCoy RC, Johnson HK, Stone WJ, Wilson CB: Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21: 642-652, 1982
8. Milliner DS, Pierides AM, Holley KE: Renal transplantation in Alport's syndrome: Anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57: 35-43, 1982
9. Kashtan C, Fish AJ, Kleppel M, Yoshioka K, Michael AF: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78: 1035-1044, 1986
10. Ding J, Zhou J, Tryggvason K, Kashtan CE: COL4A5 deletions in three patients with Alport syndrome and post-transplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5: 161-168, 1994
11. Dehan P, Van den Heuvel LP, Smeets HJ, Tryggvason K, Foidart JM: Identification of post-transplant anti-alpha 5 (IV) collagen alloantibodies in X-linked Alport syndrome. Nephrol Dial Transplant 11: 1983-1988, 1996
12. Brainwood D, Kashtan C, Gubler MC, Turner AN: Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53: 762-766, 1998
13. Kalluri R, van den Heuvel LP, Smeets HJ, Schroder CH, Lemmink HH, Boutaud A, Neilson EG, Hudson BG: A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 47: 1199-1204, 1995
14. Borza DB, Bondar O, Todd P, Sundaramoorthy M, Sado Y, Ninomiya Y, Hudson BG: Quaternary organization of the Goodpasture autoantigen, the alpha3(IV) collagen chain: Sequestration of two cryptic autoepitopes by intra-protomer interactions with the alpha4 and alpha5 NCl domains. J Biol Chem 277: 40075-40083, 2002
15. Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG: Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263: 13374-13380, 1988
16. Hellmark T, Segelmark M, Unger C, Burkhardt JH, Saus J, Wieslander J: Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 55: 936-944, 1999
17. Hellmark T, Burkhardt H, Wieslander J: Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 274: 25862-25868, 1999
18. Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, Langeveld JP, Hudson BG: The Goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem 274: 11267-11274, 1999
19. Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, Hudson BG: The Goodpasture autoantigen: Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem 275: 6030-6037, 2000
20. Gunnarsson A, Hellmark T, Wieslander J: Molecular properties of the Goodpasture epitope. J Biol Chem 275: 30844-30848, 2000
21. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10: 2981-2992, 1996
22. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): Implications for Alport syndrome. J Cell Biol 135: 1403-1413, 1996
23. Boutaud A, Borza DB, Bondar O, Gunwar S, Netzer KO, Singh N, Ninomiya Y, Sado Y, Noelken ME, Hudson BG: Type IV collagen of the glomerular basement membrane: Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem 275: 30716-30724, 2000
24. Andrews KL, Mudd JL, Li C, Miner JH: Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am J Pathol 160: 721-730, 2002
25. Lambert C, Leonard N, De Bolle X, Depiereux E: ESyPred3D: Prediction of proteins 3D structures. Bioinformatics 18: 1250-1256, 2002
26. Sundaramoorthy M, Meiyappan M, Todd P, Hudson BG: Crystal structure of NC1 domains: Structural basis for type IV collagen assembly in basement membranes. J Biol Chem 277: 31142-31153, 2002
27. Johansson C, Butkowski R, Wieslander J: Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res 25: 229-241, 1991
28. Kalluri R, Cantley LG, Kerjaschki D, Neilson EG: Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome. J Biol Chem 275: 20027-20032, 2000
29. Borza DB, Bondar O, Colon S, Todd P, Sado Y, Neilson EG, Hudson BG: Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: Novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem 280: 27147-27154, 2005
30. David M, Borza DB, Leinonen A, Belmont JM, Hudson BG: Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope. J Biol Chem 276: 6370-6377, 2001
31. Lollar P: Pathogenic antibodies to coagulation factors. Part one: Factor VIII and factor IX. J Thromb Haemost 2: 1082-1095, 2004
32. Prescott R, Nakai H, Saenko EL, Scharrer I, Nilsson IM, Humphries JE, Hurst D, Bray G, Scandella D: The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups. Blood 89: 3663-3671, 1997
33. Gubler MC, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47: 1142-1147, 1995
34. Nomura S, Naito I, Fukushima T, Tokura T, Kataoka N, Tanaka I, Tanaka H, Osawa G: Molecular genetic and immunohistochemical study of autosomal recessive Alport's syndrome. Am J Kidney Dis 31: E4, 1998
35. Kalluri R, Torre A, Shield CF 3rd, Zamborsky ED, Werner MC, Suchin E, Wolf G, Helmchen UM, van den Heuvel LP, Grossman R, Aradhye S, Neilson EG: Identification of alpha3, alpha4, and alpha5 chains of type FV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 69: 679-683, 2000
36. Querin S, Noel LH, Grunfeld JP, Droz D, Mahieu P, Berger J, Kreis H: Linear glomerular IgG fixation in renal allografts: Incidence and significance in Alport's syndrome. Clin Nephrol 25: 134-140, 1986
37. Peten E, Pirson Y, Cosyns JP, Squifflet JP, Alexandre GP, Noel LH, Grunfeld JP, van Ypersele de Strihou C: Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 52: 823-826, 1991
38. Byrne MC, Budisavljevic MN, Fan Z, Self SE, Ploth DW: Renal transplant in patients with Alport's syndrome. Am J Kidney Dis 39: 769-775, 2002
39. Kalluri R, Danoff TM, Okada H, Neilson EG: Susceptibility to anti-glomerular basement membrane disease and Good-pasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100: 2263-2275, 1997
40. Reynolds J, Pusey CD: Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 12: 61-70, 2001